Home » Epilepsy Blog » News and Research » Topomax recalled: Smells like teen spirit? Not so much

Topomax recalled: Smells like teen spirit? Not so much


When something smells bad in the ‘fridge you might call a spouse over to take a whiff. You might even go so far as to say “c’mere taste this, it smells bad doesn’t it?” But, would you just leave it in the fridge for months to see if someone mentioned it?

I don’t think so.

Topomax Recall
As a consumer of Topomax it seems like that’s exactly what  Johnson & Johnson did. The NY Times recently ran a piece by Natasha Singer on the Prescriptions blog to alert consumers of the recall. According to an article, “The company said it was recalling the drug after receiving four complaints from consumers of a strange odor, but added that there had been no reports of serious health problems associated with the complaints.” These two lots were shipped between 10/19/2010 and 12/28/2010 and distributed in the U.S. and Puerto Rico.

Smell this
Seriously? No one at J&J noticed the drug smelled bad? Since October? There were no incident reports. There was no guy in the plant saying, “Hey, c’mere smell this. Smells bad doesn’t it?” I don’t buy it.

Read the article
To read the complete article visit Prescriptions.

Let me know if you had any trouble with the drug and/or recall in the comments or at livingwellwithepilepsy@gmail.com.

author avatar
Jessica K. Smith Founder and CEO; Executive Director
Jessica Keenan Smith is a patient advocate and epilepsy community leader with more than 15 years of experience. As Founder and CEO of Living Well With Epilepsy and Executive Director of ASENT she bridges the gap between the scientific and patient communities, with a particular focus on the needs of the epilepsies. Jessica Keenan Smith is Founder and CEO of Living Well With Epilepsy, an award winning online resource for people affected by epilepsy to share stories and access in-depth information on the disease. Since 2009, Living Well With Epilepsy (https://livingwellwithepilepsy.com) has been featured in Forbes, Wired, NBC, NPR and the cover story of Epilepsy Advocate Magazine and has partnered with companies such as UCB, Lundbeck, Sunovion, Eisai, and more. Ms. Smith is also the Executive Director of the American Society for Experimental Neurotherapeutics (ASENT) (https://asent.org), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. In this role she is responsible for leading a successful scientific journal and annual scientific conference with speakers from all over the world.

  1. Morgan
    | Reply

    I see a lot of those ads about lawyers basically telling people they should sue the companies that make anti-convulsants if they have undesired side effects or something. I've been wondering about it, but don't they tell you those things? I mean when they list the possible side effects? What I get out of the commercials is “stop taking this 'cause this might happen to you.” But I wouldn't think it is safe to completely stop taking your medicine if you are a pregnant epileptic woman…

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.